SEC Form 4 · accession 0001140361-15-044639
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ward Wolff
Officer — Exec VP & CFO
Period of report
Dec 11, 2015
Accepted (ET)
Dec 15, 2015 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 11, 2015 | F | 6,522 | $8.68 | D | 221,790 | D | |
| Common StockF1,F2 | Dec 12, 2015 | F | 6,087 | $8.68 | D | 215,703 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.
- F2Includes 11,666 and 25,000 shares subject to restricted stock units granted on December 12, 2013 and December 11, 2014 respectively, that will be issued as such units vest in accordance with their terms.